(H059) A comparison study of mutation detection and allele frequency calling between unbiased genome-wide approaches and targeted NGS in pediatric myeloid neoplasms

Saturday, November 18, 2023

9:15 AM – 10:15 AM MST

Speaker(s)

Maria Namwanje, PhD (she/her/hers)

Clinical Variant Scientist
St. Jude Children's Research Hospital, Tennessee, United States